RLY-2608 is an oral allosteric pan-mutant isoform-selective PI3K inhibitor that was discovered using MD modeling and cryo-EM to identify allosteric networks and opportunities for small molecules, followed by DEL screening.
产品名:RLY-2608
货号:orb1910864
产品中文名:RLY-2608
产品详情链接:https://www.biorbyt.com/rly-2608-orb1910864.html